Shima M - Search Results

1

Comparisons of global coagulation potential and bleeding episodes in emicizumab-treated hemophilia A patients and mild hemophilia A patients.

Nakajima Y, Mizumachi K, Shimonishi N, Furukawa S, Yada K, Ogiwara K, Takeyama M, Shima M, Nogami K. Nakajima Y, et al. Among authors: shima m. Int J Hematol. 2022 Apr;115(4):489-498. doi: 10.1007/s12185-021-03276-7. Epub 2022 Jan 19. Int J Hematol. 2022. PMID: 35043383

2

Epitope localization of monoclonal antibodies against factor VIII light chain which inhibit complex formation by factor VIII with von Willebrand factor.

Shima M, Yoshioka A, Nakai H, Tanaka I, Sawamoto Y, Kamisue S, Terada S, Fukui H. Shima M, et al. Int J Hematol. 1991 Dec;54(6):515-22. Int J Hematol. 1991. PMID: 1724391

3

Changes in polypeptide-specific factor VIII antigen levels during whole blood clotting.

Tanaka I, Yoshioka A, Shima M, Fujiwara T, Terada S, Nakai H, Sawamoto Y, Kamisue S, Fukui H. Tanaka I, et al. Among authors: shima m. Int J Hematol. 1991 Dec;54(6):523-30. Int J Hematol. 1991. PMID: 1724392

4

Clinical evaluation of recombinant human factor VIII (BAY w 6240) in the treatment of hemophilia A.

Fukui H, Yoshioka A, Shima M, Tanaka I, Koshihara K, Fukutake K, Fujimaki M. Fukui H, et al. Among authors: shima m. Int J Hematol. 1991 Oct;54(5):419-27. Int J Hematol. 1991. PMID: 1756252 Clinical Trial.

5

[Spinal canal bleeding in hemophilia A].

Morichika S, Shima M, Imanaka Y, Nakajima M, Iwasaki S, Yoshioka A. Morichika S, et al. Among authors: shima m. Rinsho Ketsueki. 1995 Jul;36(7):687-93. Rinsho Ketsueki. 1995. PMID: 7563598 Review. Japanese.

6

Measurement of anti-factor VIII IgG, IgG4 and IgM alloantibodies in previously untreated hemophilia A patients treated with recombinant factor VIII. Kogenate Japanese Clinical Study Group.

Shima M, Sawamoto Y, Nakai H, Kamisue S, Murakami T, Morichika S, Tanaka I, Hayashi K, Yoshioka A. Shima M, et al. Int J Hematol. 1995 Jul;62(1):35-43. doi: 10.1016/0925-5710(95)00378-6. Int J Hematol. 1995. PMID: 7670006 Clinical Trial.

7

The use of porcine factor VIII in Japan.

Yoshioka A, Shima M, Morichika S, Terada S, Fukui H. Yoshioka A, et al. Among authors: shima m. Semin Hematol. 1994 Apr;31(2 Suppl 4):26-8. Semin Hematol. 1994. PMID: 7939769 Clinical Trial. No abstract available.

8

Thrombelastgram as a hemostatic monitor during recombinant factor VIIa treatment in hemophilia A patients with inhibitor to factor VIII.

Yoshioka A, Nishio K, Shima M. Yoshioka A, et al. Among authors: shima m. Haemostasis. 1996;26 Suppl 1:139-42. doi: 10.1159/000217256. Haemostasis. 1996. PMID: 8904189

9

[Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].

Shima M, Sawamoto Y, Kamisue M, Shibata Y, Tuzi S, Kuwabara M, Tanaka I, Tanizawa T, Tanaka A, Ueda M, Kakishita E, Yoshioka A. Shima M, et al. Rinsho Ketsueki. 1996 Nov;37(11):1303-8. Rinsho Ketsueki. 1996. PMID: 8960666 Japanese.

10

Anti-factor VIII inhibitor alloantibodies recognizing the A2 domain in the human factor VIII heavy chain poorly bind to porcine factor VIII.

Sawamoto Y, Shima M, Tanaka I, Nakai H, Kamisue S, Scandella D, Yoshioka A. Sawamoto Y, et al. Among authors: shima m. Int J Hematol. 1997 Feb;65(2):151-8. doi: 10.1016/s0925-5710(96)00555-5. Int J Hematol. 1997. PMID: 9071819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

927 results

Search Page

Filters